Umbrella Labs Retatrutide Peptide Research Use Only Program Supports High Rigor Multi Receptor Endocrine Signaling, Metabolic Pathway Mapping, And Reproducibl…

TUCSON, AZ / ACCESS Newswire / February 9, 2026 / Umbrella Labs today announced an expanded research focused program for ...
The Sanford Herald

Vialox Peptide: A Neuromodulatory Pentapeptide With Expanding Research Potential

The landscape of peptide-based research continues to broaden as investigators pursue compounds capable of interacting with molecular networks involved in cellular communication, structural maintenance ...
National Academies of Sciences%2c Engineering%2c and Medicine

Examining Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists for Central Nervous System Disorders: Proceedings of a Workshop

GLP-1 receptors are present throughout the brain and can contribute to a wide range of behaviors and conditions. (Drucker, Rinaman, Secher) Research is ongoing into which parts of the brain are ...
The New England Journal of Medicine

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes

Orforglipron is a small-molecule, nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist in clinical development for type 2 diabetes and weight management. Additional data on the efficacy and ...
eLife

Receptor Proteins: Lipids challenge ligands to control receptors

The behaviour of a receptor protein can be influenced by the presence of certain lipids in the membrane it is embedded in.